I am not too sure about this. The Wed meeting in UK probably forces FDA to have at least leave the approval/EUA door opened for LL by saying something vague to NP tomorrow. Something like decision in next couple of days or end of the week for COVID. But if UK is moving forward with LL by having a clear approval plan on Wed then FDA will approve/EUA LL. However, if UK plans to wait for the S2C result before making the final decision, then FDA will kick the can further down the road. I am expecting neutral news tomorrow (including HIV Type A meeting) and then the exciting Wed.